Christopher Flint O'Brien

Christopher Flint O'Brien

Directeur/Membre du Conseil chez Verifax Corp.

67 ans
Health Technology
Consumer Services
Health Services

Profil

Christopher Flint O'Brien is currently a Director at Verifax Corp.
He previously worked as Chairman-Medicine Department at Swedish Health Services, Medical Director at Colorado Neurological Institute and National Parkinson Foundation, Inc. He also served as Chief Medical Officer at Neurocrine Biosciences, Inc. from 2014 to 2018, at Prestwick Pharmaceuticals, Inc. from 2003 to 2005, and at Elan Pharmaceuticals, LLC from 2000 to 2003.
Additionally, he was an Associate Professor at The University of Colorado.
O'Brien received his undergraduate degree from Boston University and his doctorate from the University of Minnesota.

Postes actifs de Christopher Flint O'Brien

SociétésPosteDébut
Verifax Corp. Directeur/Membre du Conseil 30/06/2010
Tous les postes actifs de Christopher Flint O'Brien

Anciens postes connus de Christopher Flint O'Brien

SociétésPosteFin
NEUROCRINE BIOSCIENCES, INC. Directeur Technique/Scientifique/R&D 08/01/2018
Directeur Technique/Scientifique/R&D 01/01/2005
Directeur Technique/Scientifique/R&D 01/01/2003
The University of Colorado Corporate Officer/Principal -
National Parkinson Foundation, Inc. Directeur Technique/Scientifique/R&D -
Voir l'expérience en détail de Christopher Flint O'Brien

Formation de Christopher Flint O'Brien

Boston University Undergraduate Degree
University of Minnesota Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christopher Flint O'Brien

Relations

69

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
NEUROCRINE BIOSCIENCES, INC.

Health Technology

Entreprise privées6

Health Technology

Health Technology

Health Services

Health Services

National Parkinson Foundation, Inc.

Health Technology

Verifax Corp.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Christopher Flint O'Brien